To estimate the proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from humans that were sequence type (ST) 398, we surveyed 24 laboratories in 17 countries in Europe in 2007. Livestock-associated MRSA ST398 accounted for only a small proportion of MRSA isolates from humans; most were from the Netherlands,
L ivestock-associated methicillin-resistant Staphylococcus aureus (MRSA) was fi rst associated with human disease in 2003, when a MRSA clone associated with a reservoir in pigs and cattle was isolated from a human. This clone was not typable by pulsed-fi eld gel electrophoresis with SmaI macrorestriction digestion and belonged to multilocus sequence type (ST) 398 (1) . Since then, rates of MRSA ST398 carriage have been high (25%-35%) for persons in the Netherlands who have frequent contact with pigs and veal calves, but associated illness is rare (2) . However, in Europe, Asia, and the United States, invasive infections and a hospital outbreak of MRSA ST398 have been reported (3) . We estimated the proportion of MRSA isolates from humans in Europe in 2007 that were ST398.
The Study
Questionnaires were mailed to 43 laboratories in 23 European countries, selected on the basis of expertise and publications about MRSA. Questions asked for level of laboratory and typing methods used, number of MRSA isolates identifi ed in 2007, number of these isolates that were typed, and number of typed isolates that were MRSA ST398. MRSA isolates were considered to be ST398 if they 1) belonged to multilocus ST398, 2) were spa types t011, t034, t108, t567, t571, t588, t753, t898, t899, t1184, t1254, t1255, t1451, t1456, t1457, t2123, t2330, t2383, t2582, or t3013 (4; National Institute for Public Health and the Environment, unpub. data); or 3) were not typable by pulsed-fi eld gel electrophoresis with SmaI macrorestriction digestion. Laboratories were asked to report data on clinical isolates only (as opposed to screening isolates) and to provide the distribution by body site.
For each laboratory, the proportion of MRSA ST398 among all typed MRSA isolates from humans and the 95% Wilson confi dence interval (CI) were calculated. (Table 1 ). The proportions of MRSA ST398 per country were 0-11.9%; the countries with the highest proportion were the Netherlands (11.9%), Belgium (4.7%), Denmark (1.6%), and Austria (1.4%, pooled data). The proportion of isolates from blood was signifi cantly lower for MRSA ST398 than for other MRSA clinical isolates. No difference was observed for other body sites ( Table 2) .
The proportion of MRSA ST398 among human MRSA isolates correlated with pig density (Spearman ρ = 0.79, p = 0.001) and with the index combining this density with human population density (Spearman ρ = 0.76, p = 0.002). The proportion of MRSA ST398 among human MRSA isolates also correlated, although less signifi cantly, with the density of cattle <1 year of age (Spearman ρ = 0.61, p = 0.05) and with the index combining this density with human population density (Spearman ρ = 0.74, p = 0.01).
Conclusions
Livestock MRSA ST398 has been isolated from human samples from Austria (5), the Netherlands (2), Belgium (6), Italy (7), Spain (8), Germany (9), Portugal (10), Denmark (11), the Czech Republic (12), Sweden (13), and France (14) . This study demonstrated MRSA ST398 in human samples in Switzerland and Finland. Although few data have been published on the proportion of MRSA ST398 in Europe, Springer et al. (15) reported that during 2006 through mid-2008, among 1,043 human MRSA isolates in Austria, 21 (2.0%) were MRSA ST398, which is similar to the proportion (1.4%, pooled data) found in our study.
Among isolates from blood, a signifi cantly lower proportion were MRSA ST398 than other MRSA. This fi nding suggests that MRSA ST398 is associated with less severe disease, as indicated (5) .
The proportion of MRSA ST398 among human MRSA isolates in European countries correlated with pig and veal calf densities and with an index combining pig or veal calf density and human population density. In addition to the well-documented risk factor of occupational exposure to pigs and veal calves, proximity of humans to pigs and veal calves may contribute to transmission of MRSA ST398 from animals to humans. However, the fact that farms are not equally distributed throughout a country may explain the higher proportion of MRSA ST398 among MRSA isolates from humans in certain European countries and regions.
Use of readily available data bears some limitations. Laboratories were not randomly selected, which could result in selection bias. However, bias was limited because most laboratories were national reference laboratories that routinely collect MRSA isolates countrywide. Also, countries may have active national or local screening policies, may select which isolates to type, and may use typing techniques that are not always fully comparable. To minimize these variations, when possible we reported on data from clinical isolates only and excluded data from laboratories that reported few isolates and did not type most MRSA isolates. We also provided a list of MRSA spa types that at the time of the study had been identifi ed as corresponding to MRSA ST398. Other spa types and multilocus sequence types belonging to the livestockassociated MRSA clones have been recently reported (4) and were not included in our study.
This cross-national prevalence study found livestockassociated MRSA ST398 in human samples in several European countries. However, the relatively low proportion of MRSA ST398 among MRSA isolates from humans in most countries suggests that MRSA ST398 contributes to only a small fraction of all MRSA in humans. 
